Pfizer · NSE: PFIZER · BSE: 500680
Q3 FY20 results · Oct–Dec 2019
Pfizer reported revenue from operations of ₹538.18 crore (up 4.7% from Q3 FY19) and net profit of ₹139.06 crore (up 5.4% from Q3 FY19) for Q3 FY20 (Oct–Dec 2019), on a standalone basis.
| Item | Q3 FY20 | Q3 FY19 | YoY | Q2 FY20 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 538.18 | 513.79 | +4.7% | 567.06 | −5.1% |
| Other income | 58.22 | 64.35 | −9.5% | 44.75 | +30.1% |
| Total income | 596.40 | 578.14 | +3.2% | 611.81 | −2.5% |
| Profit before tax | 164.50 | 200.62 | −18.0% | 181.18 | −9.2% |
| Net profit for the period | 139.06 | 131.94 | +5.4% | 154.25 | −9.8% |
| EPS, basic (₹) | 30.40 | 28.84 | +5.4% | 33.72 | −9.8% |
| Net margin (%) | 25.8 | 25.7 | 27.2 |
Standalone
- Filed with BSE
- 14 Feb 2020, 14:39 IST
- Board meeting
- 14 Feb 2020
- Period
- 01 Oct 2019 to 31 Dec 2019
- Review status
- Unaudited
- Source
- XBRL filing on BSE